|
|
|
|
Trial | Studied trt | Control trt | patients | tags | ROB | Trial result | All cause death | Coronary death |
---|
|
CCAIT, 1994 | lovastatin | placebo | secondary prevention | | Exploratory | negative | | |
MARS, 1993 NCT | lovastatin | placebo | secondary prevention | | Exploratory | negative | | |
AFCAPS/TexCAPS, 1998 | lovastatin | placebo | primary prevention | | Low risk of bias | conclusive | | |
Excel, 1991 | lovastatin | placebo | | | Exploratory | negative | | |
Weintraub, 1994 | lovastatin | placebo | secondary prevention | | Low risk of bias | negative | | |
AFCAPS/TexCAPS (diabetic sub group), 1998 | lovastatin | placebo | diabetic patients | primary prevention | Low risk of bias | - | | |
CRISP 20mg, 1994 NCT | lovastatin | placebo | diabetic | | Exploratory | - | | |
ACAPS, 1994 NCT | lovastatin | placebo | secondary prevention | cerebral vascular disease | Exploratory | suggesting | | |
CRISP 40mg, 1994 NCT | lovastatin | placebo | diabetic | | Exploratory | - | | |
AFCAPS (women subgroup) , 1998 | Lovastatin | placebo | women | | Exploratory | negative | | |
Sahni, 1991 | lovastatin | usual care | secondary prevention | | Risk of bias | negative | | |
CLAPT, 1999 | lovastatin | usual care | secondary prevention | | Exploratory | negative | | |
|
AFCAPS/TexCAPS (diabetic sub group), 1998 | lovastatin | placebo | diabetic patients | primary prevention | Low risk of bias | - | | |